These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 6223827)

  • 1. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.
    Middlemiss DN; Fozard JR
    Eur J Pharmacol; 1983 May; 90(1):151-3. PubMed ID: 6223827
    [No Abstract]   [Full Text] [Related]  

  • 2. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
    Tricklebank MD; Forler C; Fozard JR
    Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 6. Testosterone increases the concentration of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding [corrected] at 5-HT1A receptors in the medial preoptic nucleus of the castrated male rat.
    Mendelson SD; McEwen BS
    Eur J Pharmacol; 1990 Jun; 181(3):329-31. PubMed ID: 2143479
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to antagonize the 8-hydroxy-2-di-n-propylamino)tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists.
    Ahlenius S; Larsson K
    Eur J Pharmacol; 1984 Apr; 99(4):279-86. PubMed ID: 6234182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin.
    Wikström H; Elebring T; Hallnemo G; Andersson B; Svensson K; Carlsson A; Rollema H
    J Med Chem; 1988 Jun; 31(6):1080-4. PubMed ID: 2967374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist.
    Gradin K; Pettersson A; Hjorth S; Hedner T; Arvidsson LE; Persson B
    J Pharm Pharmacol; 1985 Apr; 37(4):263-5. PubMed ID: 2860226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
    Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
    [No Abstract]   [Full Text] [Related]  

  • 14. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Hacksell U; Nilsson JL; Hjorth S; Carlsson A; Lindberg P; Sanchez D; Wikstrom H
    J Med Chem; 1981 Aug; 24(8):921-3. PubMed ID: 6460101
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonists.
    Kelly PA; Davis CJ; Goodwin GM
    Neuroscience; 1988 Jun; 25(3):907-15. PubMed ID: 2970017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L; Mellin C; Hacksell U; Andén NE
    Eur J Pharmacol; 1987 Nov; 143(1):55-63. PubMed ID: 2961582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain.
    Middlemiss DN; Palmer AM; Edel N; Bowen DM
    J Neurochem; 1986 Mar; 46(3):993-6. PubMed ID: 2419502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S; Fernandez-Guasti A; Hjorth S; Larsson K
    Eur J Pharmacol; 1986 May; 124(3):361-3. PubMed ID: 2942412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):409-12. PubMed ID: 2449711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.